Wockhardt Limited (WOCKPHARMA.BO)
INR 1450.6
(0.36%)
INR 1450.6
(0.36%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 23.56 Billion INR | 7.88% |
| 2022 | 21.84 Billion INR | -0.64% |
| 2021 | 21.98 Billion INR | -17.8% |
| 2020 | 26.74 Billion INR | -25.35% |
| 2019 | 35.82 Billion INR | 6.15% |
| 2018 | 33.74 Billion INR | -9.96% |
| 2017 | 37.47 Billion INR | -9.88% |
| 2016 | 41.58 Billion INR | 55.38% |
| 2015 | 26.76 Billion INR | 18.84% |
| 2014 | 22.52 Billion INR | 18.16% |
| 2013 | 19.06 Billion INR | -7.94% |
| 2012 | 20.7 Billion INR | -40.72% |
| 2011 | 34.92 Billion INR | 9.67% |
| 2010 | 31.84 Billion INR | -20.82% |
| 2009 | 40.21 Billion INR | -5.19% |
| 2008 | 42.41 Billion INR | 45.77% |
| 2007 | 29.09 Billion INR | 47.24% |
| 2006 | 19.76 Billion INR | 118.01% |
| 2005 | 9.06 Billion INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 FY | 23.56 Billion INR | 7.88% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 22.74 Billion INR | 0.0% |
| 2023 Q4 | 23.56 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q4 | 21.84 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 21.84 Billion INR | -0.64% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 21.71 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 27.6 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 21.98 Billion INR | -17.8% |
| 2021 Q4 | 21.98 Billion INR | 0.0% |
| 2020 Q4 | 26.74 Billion INR | 0.0% |
| 2020 FY | 26.74 Billion INR | -25.35% |
| 2020 Q2 | 21.87 Billion INR | 0.0% |
| 2019 Q2 | 25.94 Billion INR | 0.0% |
| 2019 Q4 | 35.82 Billion INR | 0.0% |
| 2019 FY | 35.82 Billion INR | 6.15% |
| 2018 Q2 | 25.39 Billion INR | 0.0% |
| 2018 Q4 | 33.74 Billion INR | 0.0% |
| 2018 FY | 33.74 Billion INR | -9.96% |
| 2017 Q4 | 37.47 Billion INR | 0.0% |
| 2017 Q2 | 34.47 Billion INR | 0.0% |
| 2017 FY | 37.47 Billion INR | -9.88% |
| 2016 Q2 | 37.07 Billion INR | 0.0% |
| 2016 FY | 41.58 Billion INR | 55.38% |
| 2016 Q4 | 41.58 Billion INR | 0.0% |
| 2015 Q2 | 17.46 Billion INR | 0.0% |
| 2015 Q4 | 26.76 Billion INR | 0.0% |
| 2015 FY | 26.76 Billion INR | 18.84% |
| 2014 FY | 22.52 Billion INR | 18.16% |
| 2014 Q2 | 10.71 Billion INR | 0.0% |
| 2014 Q4 | 22.52 Billion INR | 0.0% |
| 2013 FY | 19.06 Billion INR | -7.94% |
| 2013 Q4 | 19.06 Billion INR | 0.0% |
| 2013 Q2 | 17.02 Billion INR | 0.0% |
| 2012 Q4 | 20.7 Billion INR | 0.0% |
| 2012 FY | 20.7 Billion INR | -40.72% |
| 2011 Q4 | 34.92 Billion INR | 0.0% |
| 2011 FY | 34.92 Billion INR | 9.67% |
| 2010 FY | 31.84 Billion INR | -20.82% |
| 2009 FY | 40.21 Billion INR | -5.19% |
| 2008 FY | 42.41 Billion INR | 45.77% |
| 2007 FY | 29.09 Billion INR | 47.24% |
| 2006 FY | 19.76 Billion INR | 118.01% |
| 2005 FY | 9.06 Billion INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 352.8 Million INR | -6578.005% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -136218.926% |
| Sigachi Industries Limited | 1.43 Billion INR | -1546.957% |
| Bal Pharma Limited | 1.39 Billion INR | -1587.094% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -14074.327% |
| Medico Remedies Limited | 80.5 Million INR | -29165.627% |
| Lasa Supergenerics Limited | 220.76 Million INR | -10572.127% |
| Venus Remedies Limited | 413.3 Million INR | -5600.46% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -3752.821% |
| Alpa Laboratories Limited | 52.46 Million INR | -44806.128% |
| Nectar Lifesciences Limited | 6.35 Billion INR | -270.711% |
| Shilpa Medicare Limited | 9.37 Billion INR | -151.337% |
| Aarti Drugs Limited | 5.64 Billion INR | -317.531% |
| Lupin Limited | 29.21 Billion INR | 19.364% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 64.559% |
| Zydus Lifesciences Limited | 8.04 Billion INR | -192.962% |
| Windlas Biotech Limited | 36.41 Million INR | -64607.498% |
| Suven Life Sciences Limited | 7.09 Million INR | -331871.255% |
| Eris Lifesciences Limited | 27.81 Billion INR | 15.29% |
| Valiant Laboratories Limited | 767.08 Million INR | -2971.372% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | -523.842% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | -132.921% |
| Ipca Laboratories Limited | 14.38 Billion INR | -63.798% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -2259.773% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 28.032% |
| Bajaj HealthCare Limited | 3.32 Billion INR | -607.881% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Mankind Pharma Limited | 2.07 Billion INR | -1037.217% |
| Laurus Labs Limited | 25.77 Billion INR | 8.59% |
| Piramal Pharma Limited | 47.1 Billion INR | 49.98% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -3150.256% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 41.422% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | -359.116% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | -91.4% |
| Unichem Laboratories Limited | 2.47 Billion INR | -851.865% |
| Sequent Scientific Limited | 4.87 Billion INR | -383.091% |
| Novartis India Limited | 69.7 Million INR | -33702.009% |
| Wanbury Limited | 1.16 Billion INR | -1922.585% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -3524.816% |
| Themis Medicare Limited | 957.92 Million INR | -2359.49% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -26250.52% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 35.699% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -13639.212% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | -17.682% |
| Divi's Laboratories Limited | 30 Million INR | -78433.333% |
| NATCO Pharma Limited | 3.71 Billion INR | -534.698% |
| Gufic Biosciences Limited | 3.32 Billion INR | -607.687% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -7091.697% |
| Ind-Swift Limited | 10.13 Billion INR | -132.348% |
| Procter & Gamble Health Limited | 95.6 Million INR | -24544.351% |
| FDC Limited | 205.18 Million INR | -11382.321% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -1118.015% |
| Granules India Limited | 13.15 Billion INR | -79.155% |
| Medicamen Biotech Limited | 308.17 Million INR | -7545.081% |
| Alkem Laboratories Limited | 14.18 Billion INR | -66.101% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -51137.441% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -536696.537% |
| Brooks Laboratories Limited | 56.41 Million INR | -41658.982% |
| Megasoft Limited | 1.47 Billion INR | -1502.209% |
| ZIM Laboratories Limited | 1.08 Billion INR | -2064.956% |
| Strides Pharma Science Limited | 25.16 Billion INR | 6.391% |
| Neuland Laboratories Limited | 953.89 Million INR | -2369.871% |
| Morepen Laboratories Limited | 289.99 Million INR | -8024.362% |
| Hikal Limited | 8.17 Billion INR | -188.168% |
| Indoco Remedies Limited | 6.71 Billion INR | -250.616% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | -725.942% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -7344.741% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -2292.06% |
| Hester Biosciences Limited | 2.44 Billion INR | -864.08% |